BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25724922)

  • 1. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test.
    Tiemensma J; Pereira AM; Romijn JA; Broadbent E; Biermasz NR; Kaptein AA
    Eur J Endocrinol; 2015 May; 172(5):583-93. PubMed ID: 25724922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drawings reflect a new dimension of the psychological impact of long-term remission of Cushing's syndrome.
    Tiemensma J; Daskalakis NP; van der Veen EM; Ramondt S; Richardson SK; Broadbent E; Romijn JA; Pereira AM; Biermasz NR; Kaptein AA
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3123-31. PubMed ID: 22723334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life.
    Andela CD; Biermasz NR; Kaptein AA; Pereira AM; Tiemensma J
    Growth Horm IGF Res; 2015 Oct; 25(5):219-26. PubMed ID: 26164770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.
    Kyriakakis N; Lynch J; Gilbey SG; Webb SM; Murray RD
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):806-815. PubMed ID: 28316090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    Eur J Endocrinol; 2011 Oct; 165(4):527-35. PubMed ID: 21798958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total score or subscales in scoring the acromegaly quality of life questionnaire: using novel confirmatory methods to compare scoring options.
    Felt JM; Depaoli SA; Pereira AM; Biermasz NR; Tiemensma J
    Eur J Endocrinol; 2015 Jul; 173(1):37-42. PubMed ID: 25872514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acromegaly improves quality of life, measured by AcroQol.
    Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
    Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.
    Postma MR; Netea-Maier RT; van den Berg G; Homan J; Sluiter WJ; Wagenmakers MA; van den Bergh AC; Wolffenbuttel BH; Hermus AR; van Beek AP
    Eur J Endocrinol; 2012 Apr; 166(4):585-92. PubMed ID: 22250074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
    T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
    Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The art of perception: Patients drawing their vestibular schwannoma.
    van Leeuwen BM; Herruer JM; Putter H; van der Mey AG; Kaptein AA
    Laryngoscope; 2015 Dec; 125(12):2660-7. PubMed ID: 26059643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.
    Roerink SH; Wagenmakers MA; Wessels JF; Sterenborg RB; Smit JW; Hermus AR; Netea-Maier RT
    Pituitary; 2015 Jun; 18(3):366-75. PubMed ID: 24965695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.
    Wassenaar MJ; Biermasz NR; Kloppenburg M; van der Klaauw AA; Tiemensma J; Smit JW; Pereira AM; Roelfsema F; Kroon HM; Romijn JA
    Growth Horm IGF Res; 2010 Jun; 20(3):226-33. PubMed ID: 20194043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.
    Hua SC; Yan YH; Chang TC
    Eur J Endocrinol; 2006 Dec; 155(6):831-7. PubMed ID: 17132752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
    Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly.
    van der Klaauw AA; Biermasz NR; Hoftijzer HC; Pereira AM; Romijn JA
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):123-8. PubMed ID: 18182092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
    Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
    J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric changes correlate with poor psychological outcomes in patients with acromegaly.
    Imran SA; Tiemensma J; Kaiser SM; Vallis M; Doucette S; Abidi E; Yip CE; De Tugwell B; Siddiqi F; Clarke DB
    Eur J Endocrinol; 2016 Jan; 174(1):41-50. PubMed ID: 26586838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.